Date Name Title Filing Type Shares Traded Price Total Held
Aug 07, 2014
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 270,352 -- --
Dec 15, 2004
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 270,352 -- 270,352
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 263,000 -- --
Dec 18, 2017
Director, President & CSO
Director, President & CSO Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 257,850 $386.90 422,762
Dec 13, 2017
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 $21.92 407,409
Dec 13, 2017
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 -- --
Dec 15, 2016
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 $20.32 292,806
Dec 15, 2016
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 -- --
Oct 27, 2014
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 $11.64 292,893
Oct 27, 2014
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,000 -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.